Texas

Index
Globenewswire

Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention

Globenewswire

Persona AI Announces Michael Perry as Head of Commercial Strategy

Globenewswire

Quest Software Survey Finds That Over 75 Percent of Global Organizations Are Not Testing Identity Disaster Recovery Frequently Enough

Globenewswire

Mavenir Bermitra dengan TextNow untuk Mengembangkan Layanan MVNO 5G Berbasis Aplikasi

Globenewswire

Mavenir Partners With TextNow to Evolve App-Based 5G MVNO Service

Globenewswire

Tune Talk Menjadi Operator Jaringan Seluler yang Sepenuhnya Berbasis Cloud Pertama di ASEAN bersama Mavenir

Globenewswire

LYB announces updated 2030 sustainability goals

Globenewswire

Tune Talk Becomes ASEAN’s First Fully Cloud-Native Mobile Network Operator with Mavenir

Globenewswire

Mavenir Berkolaborasi dengan Red Hat untuk Menghadirkan AI Percakapan dan Jaminan Layanan AI Agentik Kelas Operator yang Berjalan di Infrastruktur Lokal untuk Perusahaan Telekomunikasi

Globenewswire

Mavenir Collaborates with Red Hat to Deliver Carrier-Grade On-Premise Conversational AI and Agentic AI Service Assurance for Telcos

Globenewswire

Quest Software Transforms Data Management with the Introduction of the Quest Trusted Data Management Platform Featuring the Automated Data Product Factory — the First Converged and Automated Platform Built for AI

Globenewswire

Digital Realty masuk ke Malaysia, memperkuat infrastruktur digital Asia Tenggara

Globenewswire

Digital Realty Enters Malaysia, Strengthening Southeast Asia’s Digital Backbone

Globenewswire

TNH Announces “Summer Sessions” Live Podcast Tour — Jay Walker & Shawn Murphy Take the Show on the Road This Summer

Globenewswire

Parker Seminars Announces Las Vegas 2026 (Feb. 26–28): The World’s Largest Chiropractic & Healthcare Event Celebrates 75 Years

Globenewswire

Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting kil

Globenewswire

Mavenir Mengonfirmasi Strategi Fokus Ulang pada Inti Jaringan Seluler dan Visi AI dengan Perluasan Tim Pemimpin untuk Mempercepat Penerapan Strategi Jaringan Berbasis AI

Globenewswire

Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy

Globenewswire

Io Therapeutics Presents Today at the American Society for Hematology Annual Meeting, Preclinical Studies Demonstrating Combination Treatment with BCMA CAR-T Cells Plus the Company's RXR Agonist Compound IRX4204 has Synergistic Efficacy Against Human Mult

Globenewswire

Telnyx and CommsPlus Partner to Expand Carrier-Grade Voice and AI Across ANZ

Globenewswire

Wood Mackenzie Appoints New Chief Commercial Officer

Globenewswire

Telnyx and Yeastar Partner to Empower Businesses with Complete Control Over their Unified Communications

Globenewswire

Partner Business Unit Marks Next Era of SoftServe–Microsoft Collaboration, Driving AI Impact Across Enterprises

Globenewswire

Mavenir akan Menyampaikan Info Terbaru Perusahaan dan Visinya terkait AI pada Acara Analis Global Tahunan

Globenewswire

Mavenir to Deliver Corporate Update and AI Vision at Annual Global Analyst Event